Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Thomas F. Rogers, Fangzhu Zhao, Deli Huang, +31

Science

VaccinationVaccine DevelopmentNon-rbd EpitopesEmerging Infectious DiseasesVaccine Target +13

Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses

Michela Locci, Colin Havenar‐Daughton, Elise Landais, +10

Immunity

Human RetrovirusImmunologyAntiviral ResponseAutoimmunityHiv +5

Structural basis of a shared antibody response to SARS-CoV-2

Meng Yuan, Hejun Liu, Nicholas C. Wu, +13

Science

CXCL13 is a plasma biomarker of germinal center activity

Colin Havenar‐Daughton, Madelene Lindqvist, Antje Heit, +11

Proceedings of the National Academy of Sciences

ImmunologyPlasma BiomarkerPathologyImmunodominanceImmunologic Mechanism +15

A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses

Jon M. Steichen, Ying‐Cing Lin, Colin Havenar‐Daughton, +28

Science

Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort

Elise Landais, Xiayu Huang, Colin Havenar‐Daughton, +24

PLoS Pathogens

VaccinationPrimary ImmunodeficiencyNeutralizing AntibodiesNeurovirologyHuman Retrovirus +12

An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability

Marit J. van Gils, Tom L.G.M. van den Kerkhof, Gabriel Ozorowski, +24

Nature Microbiology

Hiv-1 AntibodyHuman RetrovirusFusion PeptideImmunologyAntiviral Response +7

The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen

Colin Havenar‐Daughton, Anita Sarkar, Daniel W. Kulp, +20

Science Translational Medicine

Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch

Daniel T. MacLeod, Nancy M. Choi, Bryan Briney, +32

Immunity

Primary ImmunodeficiencyBroad Hiv-1 NeutralizationMedicineHuman RetrovirusImmunology +8

CD4⁺T-Cell Responses to Epstein-Barr Virus (EBV) Latent-Cycle Antigens and the Recognition of EBV-Transformed Lymphoblastoid Cell Lines

Heather M. Long, Tracey A. Haigh, Nancy Gudgeon, +8

Journal of Virology